# TTY Biopharm Company Limited (4105.TWO): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for TTY Biopharm Company Limited (4105.TWO) is 99/100, ranked against 24,000+ stocks in 35 markets (Quality 81, Value 70, Momentum 69, each scored against its sector).

- StockRank: 99/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 81, Value 70, Momentum 69: each a 0-100 percentile within Healthcare.
- Position: #282 overall, #35 in Healthcare.
- Listing: Taiwan, TWO; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 80.6 TWD on 23 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/4105.TWO
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker